These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17307527)

  • 1. Nasal potential difference in cystic fibrosis diagnosis of very young children.
    Sermet-Gaudelus I; Girodon E; Huet F; Aboutaam R; Bui S; Deneuville E; Guillot M; Vrielynck S; Lenoir G; Edelman A
    J Pediatr; 2007 Mar; 150(3):e34-5. PubMed ID: 17307527
    [No Abstract]   [Full Text] [Related]  

  • 2. Neonatal screening for cystic fibrosis. Early diagnosis is important to parents even if it makes little difference to outcome.
    Pollitt R
    BMJ; 1998 Aug; 317(7155):411-2. PubMed ID: 9729096
    [No Abstract]   [Full Text] [Related]  

  • 3. [Measurement of nasal transepithelial potential difference: a diagnostic test for cystic fibrosis].
    Charfi MR; Matran R; Regnard J; Lockhart A
    Rev Pneumol Clin; 1996; 52(1):9-13. PubMed ID: 8731749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The meaning of "early" diagnosis in a new era of cystic fibrosis care.
    Farrell PM
    Pediatrics; 2007 Jan; 119(1):156-7. PubMed ID: 17200282
    [No Abstract]   [Full Text] [Related]  

  • 5. Cystic fibrosis: refining the approach to newborn screening.
    Wilcken B
    J Pediatr; 2009 Nov; 155(5):605-6. PubMed ID: 19840611
    [No Abstract]   [Full Text] [Related]  

  • 6. Nasal potential difference: a clinical diagnostic test for cystic fibrosis.
    Alton EW; Currie D; Logan-Sinclair R; Warner JO; Hodson ME; Geddes DM
    Eur Respir J; 1990 Sep; 3(8):922-6. PubMed ID: 2292287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sweat test centered protocol for the disclosure and diagnosis of cystic fibrosis in a newborn screening program.
    Doull IJ; Hall SJ; Bradley DM
    Pediatr Pulmonol; 2007 Sep; 42(9):773-8. PubMed ID: 17659601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using computer based data acquisition and analysis system for nasal potential difference measurement in cystic fibrosis.
    Ergönül Z; Balkanci ZD; Yilmaz G; Kiper N; Yalçin E; Doğru D; Ozçelik U; Göçmen A
    Turk J Pediatr; 2004; 46(4):339-43. PubMed ID: 15641268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal screening for cystic fibrosis. Early diagnosis allows option of prenatal diagnosis in subsequent pregnancies.
    Lane B; Harris R; Harris H
    BMJ; 1998 Aug; 317(7155):411. PubMed ID: 9729095
    [No Abstract]   [Full Text] [Related]  

  • 10. Newborn screening for cystic fibrosis: an opportunity to improve care and outcomes.
    Campbell PW; White TB
    J Pediatr; 2005 Sep; 147(3 Suppl):S2-5. PubMed ID: 16202776
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilot newborn screening project for cystic fibrosis in the Czech Republic: defining role of the delay in its symptomatic diagnosis and influence of ultrasound-based prenatal diagnosis on the incidence of the disease.
    Balascaková M; Holubová A; Skalická V; Zemková D; Kracmar P; Gonsorcíkova L; Camajová J; Piskácková T; Lebl J; Drevínek P; Gregor V; Vávrová V; Votava F; Macek M
    J Cyst Fibros; 2009 May; 8(3):224-7. PubMed ID: 19208501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.
    Kloosterboer M; Hoffman G; Rock M; Gershan W; Laxova A; Li Z; Farrell PM
    Pediatrics; 2009 Feb; 123(2):e338-46. PubMed ID: 19171585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nasal transepithelial difference of potential in mucoviscidosis. Clinical application of the measurement].
    Maherzi A; Ategbo S; Pharaon I; Munck A; Cezard JP; Foucaud P; Navarro J
    Presse Med; 1995 Mar; 24(9):437-40. PubMed ID: 7746816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sweat-testing: a review of current technical requirements.
    Beauchamp M; Lands LC
    Pediatr Pulmonol; 2005 Jun; 39(6):507-11. PubMed ID: 15830391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Employing the nasal potential difference as a diagnostic test for cystic fibrosis in neonates: potential pitfalls.
    Gaillard EA; Shaw NJ; Subhedar NV; Wallace HL; Southern KW
    J Pediatr; 2002 Aug; 141(2):295-6. PubMed ID: 12183735
    [No Abstract]   [Full Text] [Related]  

  • 16. A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA.
    Sontag MK; Wright D; Beebe J; Accurso FJ; Sagel SD
    J Pediatr; 2009 Nov; 155(5):618-22. PubMed ID: 19540513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acidic pH hyperpolarizes nasal potential difference.
    Uwaifo O; Bamford P; Zeitlin PL; Blaisdell CJ
    Pediatr Pulmonol; 2006 Feb; 41(2):151-7. PubMed ID: 16369925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neonatal screening for cystic fibrosis: a new screening program and a new challenge].
    Farriaux JP
    Ann Biol Clin (Paris); 2002; 60(1):13-4. PubMed ID: 11830390
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cystic fibrosis and neonatal screening].
    Nau JY
    Rev Med Suisse; 2007 May; 3(110):1212. PubMed ID: 17564353
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neonatal screening of cystic fibrosis: which benefits?].
    Brouard J; Laurans M; Arion A; Kauffmann D; Sevin I; Laroche D; Travert G; Duhamel JF
    Arch Pediatr; 2005 Jun; 12(6):643-5. PubMed ID: 15904756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.